✦ LIBER ✦

The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients

✍ Scribed by Christine M. Walko; Austin J. Combest; Ivan Spasojevic; Angela Y. C. Yu; Shriya Bhushan; J. Heyward Hull; Janelle Hoskins; Delma Armstrong; Lisa Carey; Frances Collicio; E. Claire Dees

Book ID: 113028048
Publisher: Springer
Year: 2012
Tongue: English
Weight: 283 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1815-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aprepitant Pharmacokinetics and Assessin

Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

✍ Bubalo, Joseph S.; Cherala, Ganesh; McCune, Jeannine S.; Munar, Myrna Y.; Tse, S 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 404 KB

Effect of body weight on the pharmacokin

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

✍ Garth Powis; Phillip Reece; David L. Ahmann; James N. Ingle 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 427 KB

Lack of effect of aprepitant on the phar

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients

✍ Peter Nygren; Kenneth Hande; Kevin J. Petty; Margaret Fedgchin; Kristien van Dyc 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 251 KB

Population Pharmacokinetics and Pharmaco

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients

✍ Dr Markus Joerger, Alwin D. R. Huitema, Dick J. Richel, Christian Dittrich, Niko 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 237 KB

Effect of aprepitant on the pharmacokine

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin

✍ M. Depré; A. Van Hecken; M. Oeyen; I. De Lepeleire; T. Laethem; P. Rothenberg; K 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 250 KB

Pharmacokinetic/pharmacodynamic interact

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer

✍ Roy B. Jones; Steven Matthes; Christopher Dufton; Scott I. Bearman; Salomon M. S 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 609 KB